Modulation of sialic acid levels among some organs during insulin resistance or hyperglycemic states
Tóm tắt
Previous studies have suggested a possible connection between insulin resistance and chronic hyperglycemia with membrane sialic acid content. In this study, the effects of high (20 % ad libitum) fructose and glucose feeding on the sialic acid levels of some organs were investigated in rats. The blood glucose levels of the high fructose- and glucose-fed rats were consistently and significantly (P < 0.05) higher than the normal control throughout the experiment. Free serum sialic acid and total hepatic sialic acid levels were elevated in the high fructose- and glucose-fed rats compared to normal control, but only the data for the high glucose-fed group were significantly (P < 0.05) different from the normal control. Conversely, a significant (P < 0.05) decrease in the pancreatic sialic acid level was observed in high glucose-fed group compared to normal control. Also, the high fructose-fed rats had lower, but insignificant (P > 0.05), pancreatic sialic acid level than the normal control. On the other hand, high fructose and glucose feeding did not significantly (P > 0.05) affect the sialic acid levels of the skeletal muscle and heart, though a tendency to increase the sialic acid level was evident in the heart. In the kidney, the sialic acid level was significantly (P < 0.05) increased in both high fructose- and glucose-fed groups. It was concluded that the liver and kidney tend to stimulate sialic acid synthesis, while the pancreas downregulate sialic acids synthesis and/or promote sialic acid release from glycoconjugates. Also, these organs may contribute to high-serum sialic acid level observed during diabetes.
Tài liệu tham khảo
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103:137–149. doi:10.1016/j.diabres.2013.11.002
Salas-Salvado J, Martinez-Gonzalez MA, Bullo M, Ros E (2011) The role of diet in the prevention of type 2 diabetes. Nutr Metab Cardiovasc Dis 21(Suppl 2):B32–B48. doi:10.1016/j.numecd.2011.03.009
American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–S69. doi:10.2337/dc10-S062
Nayak BS, Duncan H, Lalloo S, Maraj K, Matmungal V, Matthews F, Prajapati B, Samuel R, Sylvester P (2008) Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy. Vasc Health Risk Manag 4(1):243–247
Prajna K, Ashok KJ, Srinidhi R, Shobith KS, Tirthal R, Mohamedi B, Shashikala MD (2013) Predictive value of serum sialic acid in type-2 diabetes mellitus and its complication (nephropathy). J Clin Diagn Res 7(11):2435–2437. doi:10.7860/JCDR/2013/6210.3567
Rahman I, Malik AS, Bashir M, Khan R, Iqbal M (2009) Serum sialic acid changes in non-insulin-dependent diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment. Phytomedicine 16:401–405. doi:10.1016/j.phymed.2009.01.001
Englyst NA, Crook MA, Lumb P, Stears AJ, Masding MG, Wootton SA, Sandeman DD, Bryne CD (2006) Percentage of body fat and plasma glucose predict plasma sialic acid concentration in type 2 diabetes mellitus. Metabolism 55:1165–1170
Khalili P, Sundstrom J, Jendle J, Lundin F, Jungner I, Nilsson PM (2014) Sialic acid and incidence of hospitalization for diabetes and its complications during 40-years of follow- up in a large cohort: the Värmland survey. Prim Care Diabetes 8(4):352–357. doi:10.1016/j.pcd.2014.06.002
Alghamdi F, Guo M, Abdulkhalek S, Crawford N, Amith SR, Szewczuk MR (2014) A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes. Cell Signal 26(4):1355–1368. doi:10.1016/j.cellsig.2014.02.015
Aminoff D (1961) Methods for the qualitative estimation of Nacetylneuraminic acid and their application to hydrolysis of sialomucoids. Biochem J 81:384–392
Ward C, Lawrence M, Streltsov V, Garrett T, McKern N, Lou MZ, Lovrecz G, Adams T (2008) Structural insights into ligand-induced activation of the insulin receptor. Acta Physiol (Oxf) 192(1):3–9. doi:10.1111/j.1748-1716.2007.01781.x
Sparrow LG, Lawrence MC, Gorman JJ, Strike PM, Robinson CP, McKern NM, Ward CW (2008) N-linked glycans of the human insulin receptor and their distribution over the crystal structure. Proteins 71(1):426–439
Gokmen SS, Kilicli G, Ozcelik F, Ture M, Gulen S (2002) Association between serum total and lipid-bound sialic acid concentration and the severity of coronary atherosclerosis. J Lab Clin Med 140(2):110–118
Lapolla A, Molin L, Traldi P (2013) Protein glycation in diabetes as determined by mass spectrometry. Int J Endocrinol. Article ID 412103. doi: 10.1155/2013/412103
Crook MA, Tutt P, Simpson H, Pickup JC (1993) Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus. Clin Chim Acta 219:131–138
Crook MA, Khandhadia S, Lumb P, Ridha A, Hussain A (2000) No difference in serum sialic acid in type 2 diabetic patients from the United Arab Emirates with or without diabetic retinopathy. Diabetes Res Clin Pract 47:147–150
Hininger-Favier I, Benaraba R, Coves S, Anderson RA (2009) Green tea extract decrease oxidative stress and improved insulin sensitivity in an animal model of insulin resistance, the fructose-fed rat. J Am Coll Nutr 28:355–361
Wilson R, Islam MS (2012) Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes. Pharmacol Rep 64:129–139
Leahy JL (2005) Pathogenesis of type 2 diabetes Mellitus. Arch Med Res 36:197–209